The All-Virtual 62nd Annual Society of Hematology Annual Meeting & Exposition is scheduled for December 2-11, 2020. The conference will feature research findings about many hematologic conditions, including chronic lymphocytic leukemia (CLL). Visit the ASH annual meeting website for more details.
Great talk by Daniela Robles-Espinoza @daniela_oaks highlighting the importance of studying cancer genomes from different ethnicities and also the challenges of doing genomic research in Low-Middle Income Countries. @NCIgenomics Conference in Mutational Signatures and Cancer pic.twitter.com/ZIpit7LnZo
— Nuria Lopez-Bigas (@nlbigas) December 2, 2021
Targeting cancer metabolism in the era of precision oncology | Nature Reviews Drug Discovery https://t.co/EWf6xs5yKk
— Anas Younes, M.D. (@DrAnasYounes) December 6, 2021
Impact of tissue-agnostic approvals for patients with sarcoma @trendscancer @CellPressNews https://t.co/AHdu8V9l9O
— Vivek Subbiah, MD (@VivekSubbiah) December 6, 2021
Today is the first day of #CancerScreenWeek, a public health initiative that we founded with @AmericanCancer, @SU2C and @Optum to help spread the word about the benefits of early cancer detection. Learn more: https://t.co/DVN8GN31vo https://t.co/Qgb9vzbdwv
— Genentech (@genentech) December 6, 2021
Reproducibility in Cancer Biology: Challenges for assessing replicability in preclinical cancer biologyhttps://t.co/3l3Kpi9zKP
— Anirban Maitra (@Aiims1742) December 7, 2021
“This experience draws attention to a basic and fundamental concern about replication – it is hard to assess whether reported findings are credible”
